Inovio Pharmaceuticals, Inc. (BMV:INO)

Inovio Pharmaceuticals Ratios and Metrics

Market cap in millions MXN. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	2,152	1,377	2,354	7,592	21,522	29,833
Market Cap Growth	8.68%	-41.51%	-69.00%	-64.72%	-27.86%	379.26%
Enterprise Value	1,418	-131	26	2,726	14,105	24,609
Last Close Price	31.00	39.00	99.60	342.00	1236.00	2124.00
PS Ratio	643.50	303.38	167.33	37.93	591.53	202.30
PB Ratio	-15.20	0.96	1.19	1.75	2.63	3.25
P/TBV Ratio	-	0.96	1.19	1.86	2.72	3.35
EV/Sales Ratio	-	-	1.86	13.62	387.68	166.88
Debt / Equity Ratio	-1.30	0.17	0.26	0.14	0.08	0.09
Asset Turnover	0.00	0.00	0.00	0.02	0.00	0.02
Quick Ratio	0.74	2.70	3.47	2.73	6.23	10.33
Current Ratio	0.79	2.77	3.60	3.25	6.82	11.30
Return on Equity (ROE)	-328.45%	-115.42%	-79.55%	-89.97%	-70.55%	-71.79%
Return on Assets (ROA)	-63.56%	-49.45%	-30.50%	-37.53%	-36.35%	-22.68%
Return on Capital (ROIC)	-127.02%	-61.64%	-39.41%	-46.13%	-40.36%	-25.63%
Return on Capital Employed (ROCE)	20471.70%	-144.30%	-98.70%	-100.80%	-70.00%	-24.90%
Earnings Yield	-92.12%	-162.35%	-97.05%	-71.89%	-28.93%	-11.10%
FCF Yield	-75.92%	-158.28%	-89.56%	-55.80%	-20.66%	-11.97%
Buyback Yield / Dilution	-53.38%	-22.49%	-11.51%	-14.27%	-34.62%	-57.14%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.